- Home
- ARWR vs BBWI Comparison
ARWR vs BBWI Comparison
Compare ARWR & BBWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- BBWI
- Stock Information
- Founded
- ARWR 2003
- BBWI 1963
- Country
- ARWR United States
- BBWI United States
- Employees
- ARWR N/A
- BBWI N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- BBWI Clothing/Shoe/Accessory Stores
- Sector
- ARWR Health Care
- BBWI Consumer Discretionary
- Exchange
- ARWR Nasdaq
- BBWI Nasdaq
- Market Cap
- ARWR 5.9B
- BBWI 5.0B
- IPO Year
- ARWR 1993
- BBWI N/A
- Fundamental
- Price
- ARWR $40.96
- BBWI $21.89
- Analyst Decision
- ARWR Strong Buy
- BBWI Buy
- Analyst Count
- ARWR 8
- BBWI 17
- Target Price
- ARWR $47.75
- BBWI $38.47
- AVG Volume (30 Days)
- ARWR 1.7M
- BBWI 5.5M
- Earning Date
- ARWR 11-25-2025
- BBWI 11-20-2025
- Dividend Yield
- ARWR N/A
- BBWI 3.64%
- EPS Growth
- ARWR N/A
- BBWI N/A
- EPS
- ARWR N/A
- BBWI 3.38
- Revenue
- ARWR $572,976,000.00
- BBWI $7,371,000,000.00
- Revenue This Year
- ARWR $21,287.22
- BBWI $4.09
- Revenue Next Year
- ARWR N/A
- BBWI $2.75
- P/E Ratio
- ARWR N/A
- BBWI $6.49
- Revenue Growth
- ARWR 2816.20
- BBWI N/A
- 52 Week Low
- ARWR $9.57
- BBWI $21.84
- 52 Week High
- ARWR $43.69
- BBWI $41.87
- Technical
- Relative Strength Index (RSI)
- ARWR 60.87
- BBWI 28.56
- Support Level
- ARWR $37.35
- BBWI $23.49
- Resistance Level
- ARWR $42.00
- BBWI $23.25
- Average True Range (ATR)
- ARWR 2.18
- BBWI 0.91
- MACD
- ARWR -0.28
- BBWI -0.30
- Stochastic Oscillator
- ARWR 61.35
- BBWI 1.09
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like hair and laundry.